signaling pathways that are modulated by OPN.
In this review, we will explore the putative links between OPN, immunity, inflammation, and Before the availability of antiretrovirals, HIV-associated dementia was an AIDSdefining illness seen in 20-30% of infected individuals and was associated with a severe decline in CD4+ T-lymphocytes [10] . Clinical features include short-term memory loss, mental slowing, reading and comprehension difficulties, apathy, gait disturbance, tremor and impairment of fine motor dexterity [10] .
Neuropathological features of HIV-associated dementia include HIV encephalitis, reactive astrocytosis, myelin pallor, microglial nodules, an increase in activated macrophages and resident microglia, and multi-nucleated giant cells [10, 11] . While HIV-associated dementia has declined significantly with the introduction of combination antiretroviral therapy, milder yet insidious forms of cognitive impairment that affect activities of daily living remain prevalent at a relatively high frequency [12, 13] . The term HIV-associated neurocognitive disorders (HAND) is now used to more accurately reflect the spectrum of disease now seen in the clinic [14] . There is general consensus that the inopportune release from activated HIVinfected macrophages of cytokines and factors that are toxic to cells in the CNS leads to injury, death and dysfunction of neurons as well as the aberrant function of glia [15] .
A major focus of the field is to identify a set of biomarkers that can be used not only to predict which individuals may be at risk for infected with a green-fluorescent-tagged HIV [19, 20] . Using PCR-subtractive hybridization we identified OPN as a protein that was significantly upregulated in HIV-infected monocyte-derived macrophages [9] . Knockdown studies in human macrophages revealed that HIV replication is impaired 50%, suggesting that OPN makes a significant positive contribution to the ability of HIV to replicate in macrophages [9] . to controls [9] . This is in contrast to an earlier study that used a different cohort of patients that found differences in OPN levels in the plasma amongst individuals with differing degrees of impairment, but not in CSF [18] .
This difference between the two studies might be explained by the use in the former study While age and antiretroviral drug use are factors in bone mineral density loss, HIV infection is an independent risk factor for the development of osteopenia and osteoporosis [50, 53] . Indeed, rats expressing the HIV envelope transgene show significant decreases in bone mineral density compared to normal controls [54] . are recruited to the site of growth or injury respectively, and are involved in repair [63] [64] [65] .
Whether OPN from the latter source contributes to the CSF pool of the cytokine is not currently known.
Current anti-HIV therapies that are effective in suppressing viral load do not completely reverse inflammation in the CNS [66, 67] .
Identifying the critical signaling pathways that are regulated by OPN in macrophages and microglia and whether there are any direct effects of OPN on neurons is necessary for a greater understanding of its putative role in neuronal degeneration in HIV infection and for the development of strategies to counter its action.
